These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 14520592

  • 1. Hypercalciuria in osteogenesis imperfecta type I.
    Ammenti A, Nitsch M.
    Klin Padiatr; 2003; 215(5):283-5. PubMed ID: 14520592
    [Abstract] [Full Text] [Related]

  • 2. Hypercalciuria in children severely affected with osteogenesis imperfecta.
    Chines A, Petersen DJ, Schranck FW, Whyte MP.
    J Pediatr; 1991 Jul; 119(1 Pt 1):51-7. PubMed ID: 2066859
    [Abstract] [Full Text] [Related]

  • 3. Subdural hematoma as clinical presentation of osteogenesis imperfecta.
    Groninger A, Schaper J, Messing-Juenger M, Mayatepek E, Rosenbaum T.
    Pediatr Neurol; 2005 Feb; 32(2):140-2. PubMed ID: 15664779
    [Abstract] [Full Text] [Related]

  • 4. Urinary-free amino acids in osteogenesis imperfecta.
    Cole WG, Kirby DM.
    Bone; 1986 Feb; 7(1):13-5. PubMed ID: 3964493
    [Abstract] [Full Text] [Related]

  • 5. Hypercalciuria in osteogenesis imperfecta.
    Page LA.
    J Pediatr; 1992 Feb; 120(2 Pt 1):330-1. PubMed ID: 1735837
    [No Abstract] [Full Text] [Related]

  • 6. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
    Nishi Y, Hyodo S, Yoshimitsu K, Sawano K, Yamaoka K, Seino Y, Usui T.
    Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
    [Abstract] [Full Text] [Related]

  • 7. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
    Aström E, Magnusson P, Eksborg S, Söderhäll S.
    Acta Paediatr; 2010 Dec; 99(12):1834-40. PubMed ID: 20726960
    [Abstract] [Full Text] [Related]

  • 8. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA, Ford L, McClintock C, Peacock M.
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [Abstract] [Full Text] [Related]

  • 9. [Osteogenesis imperfecta].
    Forin V.
    Presse Med; 2007 Dec; 36(12 Pt 2):1787-93. PubMed ID: 17560761
    [Abstract] [Full Text] [Related]

  • 10. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C, Rauch F, Travers R, Glorieux FH.
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [Abstract] [Full Text] [Related]

  • 11. Hypercalciuria in osteogenesis imperfecta: a follow-up study to assess renal effects.
    Chines A, Boniface A, McAlister W, Whyte M.
    Bone; 1995 Mar; 16(3):333-9. PubMed ID: 7786636
    [Abstract] [Full Text] [Related]

  • 12. The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.
    Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH.
    Bone; 2006 Jan; 38(1):13-20. PubMed ID: 16162424
    [Abstract] [Full Text] [Related]

  • 13. [Osteogenesis imperfecta in monozygotic twins in Burundi].
    Armstrong O, Karayuba R, Ngendahayo L, Habonimana E.
    Med Trop (Mars); 1994 Jan; 54(1):59-62. PubMed ID: 8196529
    [Abstract] [Full Text] [Related]

  • 14. Osteogenesis imperfecta. A clinical and biochemical study of a generalized connective tissue disorder.
    Smith R, Francis MJ, Bauze RJ.
    Q J Med; 1975 Oct; 44(176):555-73. PubMed ID: 1202551
    [Abstract] [Full Text] [Related]

  • 15. The prognosis for walking in osteogenesis imperfecta.
    Daly K, Wisbeach A, Sanpera I, Fixsen JA.
    J Bone Joint Surg Br; 1996 May; 78(3):477-80. PubMed ID: 8636190
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta.
    Rosenberg E, Lang R, Boisseau V, Rojanasathit S, Avioli LV.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):346-55. PubMed ID: 557059
    [Abstract] [Full Text] [Related]

  • 17. [Vertebral density of hypercalciuric lithiasis. Its relation to calcium-protein intake and vitamin D metabolism].
    Lalau JD, Achard JM, Bataille P, Bergot C, Jans I, Boudailliez B, Petit J, Henon G, Westeel PF, el Esper N.
    Ann Med Interne (Paris); 1992 Feb; 143(5):293-8. PubMed ID: 1482031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of bone cells from a patient with osteogenesis imperfecta type 1b.
    Puzas JE, Brand JS, Jackman KV.
    Bone Miner; 1986 Oct; 1(5):373-82. PubMed ID: 2849487
    [Abstract] [Full Text] [Related]

  • 20. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J, Sochett E, Howard A.
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.